ArticleNPJ breast cancer2024

Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab.

S M Chew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.